Tectonic Therapeutic, Inc. (TECX) Cash Flow Statement
Tectonic Therapeutic, Inc. (TECX) generated -$72.1M of operating cash flow over the twelve months to 2026-06-30, spent $279000 on capital expenditure and had free cash flow of -$72.4M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TECXTectonic Therapeutic, Inc.Follow TECX — free
—
Price chart with a free account
- Market cap
- 392.4M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -37.6 | -67.7 | -98.8 | -98.0 | -97.2 | -40.7 | -59.1 | -60.1 | -72.1 | |
| Capital expenditure | 1.8 | 1.6 | 1.2 | 2.5 | 0.3 | 0.3 | 0.2 | 0.2 | -0.3 | |
| Free cash flow | -39.5 | -69.3 | -100.0 | -100.5 | -97.5 | -41.0 | -59.2 | -60.3 | -72.4 | |
| Stock-based compensation | 2.2 | 6.8 | 15.6 | 18.6 | 11.5 | 1.1 | 3.5 | 10.5 | — |
USD millions · SEC XBRL
Tectonic Therapeutic, Inc. — questions
- What is Tectonic Therapeutic, Inc.'s operating cash flow?
- -$72.1M over the twelve months to 2026-06-30.
- How much does Tectonic Therapeutic, Inc. spend on capital expenditure?
- $279000 over the twelve months to 2026-06-30.
- What is Tectonic Therapeutic, Inc.'s free cash flow?
- -$72.4M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Tectonic Therapeutic, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.